SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-006062
Filing Date
2023-04-17
Accepted
2023-04-17 16:15:58
Documents
89
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nbrv-20221231x10k.htm   iXBRL 10-K 3621287
2 EX-10.60 nbrv-20221231xex10d60.htm EX-10.60 66552
3 EX-10.61 nbrv-20221231xex10d61.htm EX-10.61 70590
4 EX-10.62 nbrv-20221231xex10d62.htm EX-10.62 32474
5 EX-21.1 nbrv-20221231xex21d1.htm EX-21.1 6326
6 EX-23.1 nbrv-20221231xex23d1.htm EX-23.1 2779
7 EX-31.1 nbrv-20221231xex31d1.htm EX-31.1 11377
8 EX-31.2 nbrv-20221231xex31d2.htm EX-31.2 11198
9 EX-32.1 nbrv-20221231xex32d1.htm EX-32.1 6371
10 EX-32.2 nbrv-20221231xex32d2.htm EX-32.2 6582
  Complete submission text file 0001558370-23-006062.txt   11871133

Data Files

Seq Description Document Type Size
11 EX-101.SCH nbrv-20221231.xsd EX-101.SCH 77418
12 EX-101.CAL nbrv-20221231_cal.xml EX-101.CAL 75657
13 EX-101.DEF nbrv-20221231_def.xml EX-101.DEF 320269
14 EX-101.LAB nbrv-20221231_lab.xml EX-101.LAB 666867
15 EX-101.PRE nbrv-20221231_pre.xml EX-101.PRE 504725
83 EXTRACTED XBRL INSTANCE DOCUMENT nbrv-20221231x10k_htm.xml XML 1723592
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37558 | Film No.: 23824149
SIC: 2834 Pharmaceutical Preparations